These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22941060)
1. The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer. Cui T; Chen Y; Yang L; Knösel T; Huber O; Pacyna-Gengelbach M; Petersen I Carcinogenesis; 2012 Dec; 33(12):2326-33. PubMed ID: 22941060 [TBL] [Abstract][Full Text] [Related]
2. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation. Chen Y; Cui T; Knösel T; Yang L; Zöller K; Petersen I Lung Cancer; 2011 Jul; 73(1):38-44. PubMed ID: 21095038 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic impact of desmocollins in human lung cancer. Cui T; Chen Y; Yang L; Mireskandari M; Knösel T; Zhang Q; Kohler LH; Kunze A; Presselt N; Petersen I J Clin Pathol; 2012 Dec; 65(12):1100-6. PubMed ID: 23002285 [TBL] [Abstract][Full Text] [Related]
4. DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. Cui T; Chen Y; Yang L; Knösel T; Zöller K; Huber O; Petersen I Br J Cancer; 2011 Mar; 104(6):1013-9. PubMed ID: 21364582 [TBL] [Abstract][Full Text] [Related]
5. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer. Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Albring KF; Huber O; Petersen I Carcinogenesis; 2012 Oct; 33(10):1863-70. PubMed ID: 22791817 [TBL] [Abstract][Full Text] [Related]
6. Desmocollin 3 has a tumor suppressive activity through inhibition of AKT pathway in colorectal cancer. Cui T; Yang L; Ma Y; Petersen I; Chen Y Exp Cell Res; 2019 May; 378(2):124-130. PubMed ID: 30857973 [TBL] [Abstract][Full Text] [Related]
7. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway. Hsu TS; Chen C; Lee PT; Chiu SJ; Liu HF; Tsai CC; Chao JI Cancer Chemother Pharmacol; 2008 Oct; 62(5):799-808. PubMed ID: 18193228 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma]. Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553 [TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
10. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Han S; Sidell N; Roman J Cancer Lett; 2005 Feb; 219(1):71-81. PubMed ID: 15694666 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629 [TBL] [Abstract][Full Text] [Related]
12. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205 [TBL] [Abstract][Full Text] [Related]
13. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
14. E-cadherin, as a negative regulator of invasive behavior of human trophoblast cells, is down-regulated by cyclosporin A via epidermal growth factor/extracellular signal-regulated protein kinase signaling pathway. Zhao HB; Wang C; Li RX; Tang CL; Li MQ; Du MR; Hou XF; Li DJ Biol Reprod; 2010 Sep; 83(3):370-6. PubMed ID: 20427760 [TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53. Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750 [TBL] [Abstract][Full Text] [Related]
16. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer. Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719 [TBL] [Abstract][Full Text] [Related]
17. FRS2beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding. Iejima D; Minegishi Y; Takenaka K; Siswanto A; Watanabe M; Huang L; Watanabe T; Tanaka F; Kuroda M; Gotoh N Oncogene; 2010 May; 29(21):3087-99. PubMed ID: 20228838 [TBL] [Abstract][Full Text] [Related]
18. Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis. Pan J; Chen Y; Mo C; Wang D; Chen J; Mao X; Guo S; Zhuang J; Qiu S PLoS One; 2014; 9(3):e92815. PubMed ID: 24664224 [TBL] [Abstract][Full Text] [Related]
19. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410 [TBL] [Abstract][Full Text] [Related]
20. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]